Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 - ScienceDirect
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives | Nature Reviews Cardiology
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 | JACC: Clinical Electrophysiology
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019 | Journal of the American Heart Association
A Double-Edged Sword—Cardiovascular Concerns of Potential Anti-COVID-19 Drugs | SpringerLink
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society - Canadian Journal of Cardiology
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic | SpringerLink
Frontiers | Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
Sci. Pharm. | Free Full-Text | The Potential Benefit of Beta-Blockers for the Management of COVID-19 Protocol Therapy-Induced QT Prolongation: A Literature Review
Cureus | Cardiac Adverse Events With Remdesivir in COVID-19 Infection | Article
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis - The Lancet
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic | SpringerLink
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) - Mayo Clinic Proceedings
Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19 - Cardiac Electrophysiology Clinics
Natural Products in Combination Therapy for COVID-19: QT Prolongation and Urgent Guidance - Mahdieh Eftekhari, Ayesheh Enayati, Amir Hossein Doustimotlagh, Mohammad Hosein Farzaei, Ina Yosifova Aneva, 2021
Some COVID-19 treatments prompt arrhythmia concerns; management strategy needed
COVID-19: Management in hospitalized adults - UpToDate
A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient - ScienceDirect
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic | SpringerLink
Investigational Antivirals for Managing COVID-19
Drug-Induced Long QT Syndrome | Pharmacological Reviews
SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes - Heart Rhythm
A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient - ScienceDirect
